July 2 (Reuters) - Middlebrook Pharmaceuticals Inc (MBRK.O) said on Tuesday Chief Executive Edward Runic will resign as part of a deal under which Equity Group Investments will invest $100 million of equity in the company.
John Thievon will replace Runic on closing of the transaction, Middlebrook said in a statement. (Reporting by Ajay Kamalakaran in Bangalore)
© Thomson Reuters 2009 All rights reserved
NKorea's Kim has cancer-TV
Urumqi death toll 'could rise'
Japan PM to call election
Lightning near Shuttle's launch pad
Lots of ladybugs in Colorado
Many dead in Mogadishu fighting
Suspected Nazi camp guard charged
Italian hostage freed
Mexico drugs arrest sparks violence
Many die in Pakistan school blast
Join the Reuters Consumer Insight Panel and help us get to know you better
Reuters.com:
Help and Contact Us |
Advertise With Us |
Mobile |
Newsletters |
RSS
|
Labs |
Archive |
Site Index |
Video Index
Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers
International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
